By Juan Pastor-Cervantes, MD

As a physician who treats hypertension daily, I’m constantly reminded that high blood pressure isn’t a single disease with a single solution. It is a chronic, multifaceted condition that affects millions of people and remains one of the leading contributors to heart attack, stroke and kidney disease. Among those affected is a group of patients who, despite adhering to traditionally effective medications and well-established lifestyle recommendations, continue to experience blood pressure that is difficult to control and/or challenging to manage long term.

Over the past several months, I have performed several renal denervation procedures using the Symplicity platform, and these recent cases have reinforced important lessons about the evolving landscape of hypertension treatment.

Each patient I treated shared a familiar story. They had been living with hypertension for years, had tried multiple medications, often in combination, with many experiencing side effects that made adherence a challenge. Some saw temporary improvements only to have their blood pressure rise again over time.

Identifying appropriate candidates

Before offering renal denervation, which disrupts overactive sympathetic nerves in the renal arteries, reducing their signaling to the kidneys and helping to lower blood pressure, careful evaluation is essential. Since hypertension can be influenced by many factors, including secondary causes, medication interactions and lifestyle contributors, renal denervation shouldn’t be presented as a shortcut or a replacement for medications, but as an additional option for selected patients after thoughtful discussion.

Patient selection is critically important. Renal denervation is not appropriate for everyone, and not every patient will experience the same degree of benefit. Honest conversations about potential outcomes are essential. In my practice, transparency has strengthened trust and improved long-term engagement. Patients who understand both the potential and the limitations of the procedure tend to be more satisfied with their care, regardless of the degree of blood pressure reduction achieved.

Communication with selected patients is especially important before the procedure. Spending time explaining the physiology of renal nerves and how this can contribute to persistent high blood pressure is essential. I also emphasize that renal denervation works gradually and that success is measured over months, not days, to set up a realistic timeline expectation for results.

From a procedural standpoint, the recent cases were notable for their consistency. Renal denervation is minimally invasive and catheter-based, and for patients, the experience is often less intimidating than anticipated. Most are awake and comfortable, closely monitored and able to return home the same day.

Post-procedure

In the weeks following the procedure, blood pressure readings are tracked carefully, medications are reviewed and patients are encouraged to remain engaged in lifestyle measures. Blood pressure does not suddenly normalize overnight, but many patients demonstrate improved stability and downward trends over time.

One of the most striking observations from these cases has been the psychological shift in patients. Chronic hypertension carries an invisible burden, and when medications fail to deliver consistent control, patients often internalize that failure. Renal denervation helps reframe the conversation. It reinforces that hypertension is not simply about willpower or compliance, but about complex physiological pathways that sometimes require different approaches. Several patients have shared that they feel more hopeful and more in control of their health, even early in the follow-up period.

From a physician’s perspective, performing multiple recent renal denervation cases has deepened my appreciation for individualized care. Hypertension management cannot rely solely on algorithms. It requires listening to patients, understanding their experiences with prior therapies and adapting strategies to meet their needs. Renal denervation adds another dimension to that personalized approach.

These cases have also highlighted the value of team-based care. Successful renal denervation programs depend on coordination between physicians, nursing staff, procedural teams and outpatient follow-up providers. Clear communication and consistent protocols ensure patient safety and continuity of care.

Moving forward

Looking ahead, I view renal denervation as a thoughtful evolution in the management of resistant hypertension. It does not replace existing therapies. Instead, it acknowledges that some patients need more than traditional pathways to control hypertension.

For patients reading about renal denervation and wondering whether it might be right for them, my advice is simple: have an informed conversation with your physician. Ask about your blood pressure history, your response to medications and your long-term risk. Understand that no single treatment defines success. Hypertension management is a journey, and new options are most effective when integrated into comprehensive care.

As a physician, these recent Symplicity renal denervation cases have reinforced why I value thoughtful innovation. They have expanded the way I approach hypertension, strengthened relationships with patients and reminded me that progress in medicine is measured not only in numbers, but in confidence, engagement and quality of life. That perspective – grounded in experience, evidence and patient partnership – is what continues to guide my practice as hypertension treatment evolves.

Dr. Juan Pastor-Cervantes is medical director of Memorial Healthcare System’s Cardiac Catheterization Laboratory. For more information on total heart care, visit mhs.net/services/cardiac-vascular.